Alam / Pongprutthipan Body Rejuvenation

1. Auflage 2010
ISBN: 978-1-4419-1093-6
Verlag: Springer
Format: PDF
Kopierschutz: 1 - PDF Watermark

E-Book, Englisch, 250 Seiten

As patients and physicians have become familiar with facial rejuvenation procedures, there is growing interest in adapting techniques for use off the face. The same lasers, fillers, and other techniques that can improve the appearance of the forehead or lips, are useful for the chest or hands. Body Rejuvenation is the first practical manual that describes off-the-face minimally invasive rejuvenation. Sections are organized by body area, and within each section, individual chapters contain step-by-step treatment algorithms. Chapters are brief and concise by design, so interested readers can readily obtain the information necessary to treat patients successfully. Expert authors share their experience with body rejuvenation, so that you don't have to learn by trial and error.

Autoren/Hrsg.

Alam, Murad

Pongprutthipan, Marisa

Inhaltsverzeichnis

1;Contents;5
2;Contributors;8
3;Part I Neck and Upper Chest;13
3.1;Chapter 1;14
3.1.1;Treatment of Platysmal Bands with Botulinum Toxin;14
3.1.1.1;Introduction;14
3.1.1.2;Clinical Examination;14
3.1.1.3;Treatment Indications;14
3.1.1.3.1;Setting Selection;14
3.1.1.3.2;Treatment Technique;15
3.1.1.3.3;Alternative Treatment Methods;17
3.1.1.3.4;Combinations of Botulinum Toxins with Other Modalities;18
3.1.1.4;Conclusion;18
3.1.2;References;18
3.2;Chapter 2;19
3.2.1;Treatment of Neck Laxity with Radiofrequency and Infrared Light;19
3.2.1.1;Introduction;19
3.2.1.2;Clinical Examination and Patient History;19
3.2.1.3;Method of Device or Treatment Application;19
3.2.1.3.1;Radiofrequency;19
3.2.1.3.1.1;Dose/Settings;19
3.2.1.3.1.2;Postoperative Care;22
3.2.1.3.1.3;Management of Adverse Events;22
3.2.1.3.2;Infrared Wavelengths;23
3.2.1.3.2.1;Infrared Light (1,100–1,800 nm, Titan, Cutera);23
3.2.1.3.2.2;1,310 nm Diode Laser (Candela);24
3.2.1.3.2.3;Minimally-Invasive Radiofrequency (Miratone System, Primaeva Medical, Inc., Pleasanton, CA);24
3.2.1.4;Conclusion;25
3.3;Chapter 3;26
3.3.1;Treatment of Neck Laxity with Therapeutic Ultrasound;26
3.3.1.1;Introduction;26
3.3.1.2;Patient History and Clinical Examination;26
3.3.1.3;Method of Device or Treatment Application;28
3.3.1.3.1;Dose/Setting Selection;28
3.3.1.3.2;Treatment Technique;28
3.3.1.3.3;Alternative Treatment Methods;29
3.3.1.3.4;Postoperative Care;29
3.3.1.3.5;Management of Adverse Events;29
3.3.1.4;Conclusion;30
3.3.2;References;30
3.4;Chapter 4;31
3.4.1;Treatment of Neck Fat with Injectable Adipolytic Therapy;31
3.4.1.1;Introduction;31
3.4.1.2;Clinical Examination and Patient History;31
3.4.1.3;Method of Treatment Application;33
3.4.1.4;Adverse Effects;35
3.4.1.4.1;Local Effects;35
3.4.1.4.1.1;Immediately After Injection – Day 1;35
3.4.1.4.1.2;Days 2–3;35
3.4.1.4.1.3;Day 3 to 1 Week;35
3.4.1.4.1.4;Weeks 2–4;35
3.4.1.4.1.5;Weeks 4+;36
3.4.1.4.2;Systemic Effects;36
3.4.1.5;Conclusion;36
3.4.2;Suggested Reading;36
3.5;Chapter 5;38
3.5.1;Treatment of Poikiloderma with Fractional Resurfacing;38
3.5.1.1;Introduction;38
3.5.1.2;Clinical Examination and Patient History;38
3.5.1.3;Method of Device or Treatment Application;39
3.5.1.4;Direction for the Future and Conclusions;42
3.5.2;References;44
3.6;Chapter 6;45
3.6.1;Treatment of Poikiloderma with Chemical Peeling;45
3.6.1.1;Introduction;45
3.6.1.2;Clinical Examination and Patient History;46
3.6.1.2.1;Preoperative Evaluation;46
3.6.1.2.2;Patient Evaluation;46
3.6.1.3;Treatment Application;47
3.6.1.3.1;Preoperative Patient Preparation;47
3.6.1.3.2;Chemical Peels;47
3.6.1.3.3;Postoperative Care;50
3.6.1.4;Conclusion;50
3.6.2;References;51
3.7;Chapter 7;52
3.7.1;Treatment of Poikiloderma by Pigment and Vascular Lasers;52
3.7.1.1;Introduction;52
3.7.1.2;Method of Device on Treatment Application;52
3.7.1.2.1;Argon Laser;53
3.7.1.2.2;Potassium-titanyl-phosphate Laser;53
3.7.1.2.3;Pulsed Dye Laser;53
3.7.1.2.4;Intense Pulsed Light;54
3.7.1.2.4.1;Alternative Treatment of Poikiloderma of Civatte;55
3.7.1.3;Conclusion;56
3.7.2;References;56
4;Part II Back and Chest;57
4.1;Chapter 8;58
4.1.1;Treatment of Truncal Acne Scarring;58
4.1.1.1;Introduction;58
4.1.1.2;Patient History and Clinical Examination;58
4.1.1.3;Therapeutic Considerations and Applications;58
4.1.1.3.1;Excision;58
4.1.1.3.2;Pulsed Dye Laser;60
4.1.1.3.3;Ablative Lasers;61
4.1.1.3.4;Semi-ablative Lasers;61
4.1.1.3.5;Nonablative Lasers;61
4.1.1.3.6;Intralesional Corticosteroids;62
4.1.1.3.7;Fillers;62
4.1.1.4;Conclusion;62
4.1.2;References;62
4.2;Chapter 9;63
4.2.1;Truncal Hair Removal;63
4.2.1.1;Introduction;63
4.2.1.2;Clinical Examination;63
4.2.1.3;Treatment Application;63
4.2.1.4;Conclusion;65
4.2.2;References;66
4.3;Chapter 10;67
4.3.1;Revision of Disfiguring Surgical Scars of the Back;67
4.3.1.1;Introduction;67
4.3.1.2;Clinical Examination and Patient History;67
4.3.1.3;Treatment Methods;69
4.3.1.3.1;Topical Treatments;69
4.3.1.3.2;Intralesional Injections;70
4.3.1.3.3;Cryosurgery;70
4.3.1.3.4;Laser Treatments;70
4.3.1.3.5;Surgical Treatments;71
4.3.1.4;Conclusion;72
4.3.2;References;72
5;Part III Breast;73
5.1;Chapter 11;74
5.1.1;Breast Reduction Through Liposuction;74
5.1.1.1;Introduction;74
5.1.1.2;Clinical Examination and Patient History;74
5.1.1.3;Method of Device and Treatment Application;74
5.1.1.4;Results and Postoperative Care;76
5.1.1.5;Management of Adverse Events;76
5.1.1.6;Conclusion;77
5.1.2;References;77
5.2;Chapter 12;78
5.2.1;Botulinum Toxin A for Upper Thoracic Posture and the Appearance of a “Breast Lift”;78
5.2.1.1;Introduction;78
5.2.1.2;Clinical Examination;78
5.2.1.3;Patient Selection;78
5.2.1.4;Treatment Application;78
5.2.1.5;Treatment Technique;79
5.2.1.5.1;Clinical Trial;80
5.2.1.5.2;Special Considerations;81
5.2.1.6;Conclusion;82
5.2.2;References;83
6;Part IV Hands (and Feet);84
6.1;Chapter 13;85
6.1.1;Treatment of Keratoses and Lentigines with Peels and PDT;85
6.1.1.1;Introduction;85
6.1.1.2;Patient History and Clinical Examination;85
6.1.1.3;Method of Device and Treatment Application;86
6.1.1.3.1;Photodynamic Therapy;86
6.1.1.3.2;Chemical Peeling;87
6.1.1.4;Conclusion;88
6.1.2;References;88
6.2;Chapter 14;89
6.2.1;Off-Face Laser Treatment of Keratoses and Lentigines;89
6.2.1.1;Introduction;89
6.2.1.2;Clinical Examination and Patient History;89
6.2.1.3;Method of Device and Treatment Application;89
6.2.1.3.1;532 nm Q-Switched Nd:YAG and 694 nm QS Ruby Lasers;89
6.2.1.3.2;1,550 nm Erbium-Doped Fractional Photothermolysis (Fraxel™);92
6.2.1.3.3;Laser-Mediated Photodynamic Therapy with Pulsed Dye Laser (PDL) (595 nm);96
6.2.1.4;Conclusion;98
6.2.2;References;98
6.3;Chapter 15;99
6.3.1;Treatment of Hand Veins with Sclerotherapy;99
6.3.1.1;Introduction;99
6.3.1.2;Clinical Examination and Patient History;100
6.3.1.3;Method of Device and Treatment Application;100
6.3.1.4;Conclusion;103
6.3.2;References;103
6.4;Chapter 16;104
6.4.1;Treatment of Hand Atrophy with Fat Transplantation;104
6.4.1.1;Introduction;104
6.4.1.2;Clinical Examination;104
6.4.1.3;Treatment Application;104
6.4.1.3.1;Anesthesia Considerations;104
6.4.1.3.2;Fat Harvesting;105
6.4.1.3.3;Fat Processing;106
6.4.1.3.4;Fat Injections;106
6.4.1.3.5;Postoperative Management;107
6.4.2;Reference;107
7;Part V Arms (and Legs);108
7.1;Chapter 17;109
7.1.1;Reduction of Arm Fat by Liposuction;109
7.1.1.1;Introduction;109
7.1.1.1.1;Indications;109
7.1.1.2;Clinical Examination and Patient History;109
7.1.1.2.1;Contraindications;109
7.1.1.3;Treatment Application;109
7.1.1.3.1;Procedural Protocol;109
7.1.1.3.1.1;Tray Setup;109
7.1.1.3.1.2;Relevant Anatomical Structures;110
7.1.1.3.1.3;Anesthesia;110
7.1.1.3.1.4;Technique;110
7.1.1.3.2;Postoperative Instructions;111
7.1.1.3.3;Complications;113
7.1.1.3.4;Pearls;113
7.1.1.4;Conclusion;113
7.1.2;References;113
7.2;Chapter 18;114
7.2.1;Reduction of Excess Arm Skin via Surgical Excision;114
7.2.1.1;Introduction;114
7.2.1.2;Clinical Examination and Patient History;114
7.2.1.3;Treatment Application;115
7.2.1.4;Outcomes and Complications;117
7.2.1.5;Conclusion;117
7.2.2;References;117
7.3;Chapter 19;118
7.3.1;Skin Tightening of the Arms and Legs with Radiofrequency and Broadband Light;118
7.3.1.1;Introduction;118
7.3.1.2;Clinical Examination;120
7.3.1.3;Treatment Application;120
7.3.1.4;Conclusion;121
7.3.2;References;122
7.4;Chapter 20;123
7.4.1;Sclerotherapy of Leg Veins;123
7.4.1.1;Introduction;123
7.4.1.2;Clinical Exam and Patient Selection;123
7.4.1.3;Treatment Application;124
7.4.1.3.1;Sclerosants;124
7.4.1.3.2;Treatment Algorithm for Large and Small Vessels;124
7.4.1.3.3;Foam Sclerotherapy;127
7.4.1.3.4;Compression;128
7.4.1.3.5;Postoperative Care;128
7.4.1.3.6;Management of Adverse Events;129
7.4.1.4;Conclusion;129
7.4.2;References;129
7.5;Chapter 21;130
7.5.1;Ambulatory Phlebectomy;130
7.5.1.1;Introduction;130
7.5.1.1.1;Indications;130
7.5.1.1.2;Contraindications;130
7.5.1.1.3;Relative Contraindications;130
7.5.1.2;Clinical Examination and Patient History;130
7.5.1.3;Treatment Application;131
7.5.1.3.1;Procedural Protocol;131
7.5.1.3.1.1;Tray Setup;131
7.5.1.3.1.2;Technique (Fig. 21.3);131
7.5.1.4;Postoperative Instructions;136
7.5.1.5;Alternative Treatment Methods;136
7.5.1.6;Complications;136
7.5.1.7;Pearls;136
7.5.1.8;Conclusion;137
7.5.2;References;138
7.6;Chapter 22;139
7.6.1;Endovenous Laser and Radiofrequency Treatment of Leg Veins;139
7.6.1.1;Introduction;139
7.6.1.2;Endovenous Laser Therapy1–7;139
7.6.1.3;Endovenous Radiofrequency Ablation3,6,8;140
7.6.1.3.1;Indications for Endovenous Ablation;141
7.6.1.3.2;Contraindications;141
7.6.1.3.3;Relative Contraindications;142
7.6.1.4;Clinical Examination and Patient History;142
7.6.1.4.1;Preoperative Evaluation;142
7.6.1.4.2;Treatment Application;142
7.6.1.4.2.1;Procedural Protocol;142
7.6.1.4.3;Postoperative Instructions;145
7.6.1.4.4;Alternative Treatment Methods;145
7.6.1.4.5;Complications;145
7.6.1.4.6;Pearls;146
7.6.1.5;Conclusion;146
7.6.2;References;146
8;Part VI Abdomen, Thighs, Hips, and Buttocks;147
8.1;Chapter 23;148
8.1.1;Noninvasive Body Rejuvenation;148
8.1.1.1;Introduction;148
8.1.1.2;Patient History and Clinical Examination;148
8.1.1.3;Method of Device or Treatment Application;154
8.1.1.3.1;Dosages and Settings;154
8.1.1.3.2;Treatment Techniques by Device;154
8.1.1.3.3;Postoperative Care;156
8.1.1.3.4;Management of Adverse Events;156
8.1.1.4;Conclusion;156
8.1.2;References;158
8.2;Chapter 24;160
8.2.1;Reduction of Cellulite with Subcision®;160
8.2.1.1;Introduction: Evidence from Literature;160
8.2.1.2;*Levels of Evidence;160
8.2.1.3;Clinical Examination and Patient Selection;160
8.2.1.3.1;Contraindications;160
8.2.1.4;Method of Device and Treatment Application;161
8.2.1.4.1;Preoperative Recommendations;161
8.2.1.4.2;Treatment of Cellulite with Subcision® Technique;161
8.2.1.4.3;Postoperative Recommendations;162
8.2.1.4.4;Results;162
8.2.1.5;Complications, Postoperative Care, and Management of Adverse Events;162
8.2.1.6;Conclusion;164
8.2.2;References;164
8.3;Chapter 25;165
8.3.1;Body Contouring with Tumescent Liposuction;165
8.3.1.1;Introduction;165
8.3.1.2;Clinical Examination and Patient History;165
8.3.1.3;Method of Treatment;166
8.3.1.3.1;Liposuction of the Arms;172
8.3.1.3.2;Liposuction of the Trunk;172
8.3.1.3.2.1;Upper and Lower Abdomen;172
8.3.1.3.2.2;Hips;173
8.3.1.3.2.3;Mid-lower Back and Waistline;174
8.3.1.3.3;Liposuction of the Buttock;175
8.3.1.3.4;Liposuction of the Legs;175
8.3.1.3.4.1;Outer Thighs;176
8.3.1.3.4.2;Inner Thighs and Knees;179
8.3.1.3.5;Love Handles and Abdomen on Men;180
8.3.1.3.6;Postoperative Clinical Considerations;182
8.3.1.4;Conclusion;183
8.3.1.5;Box 25.1;166
8.3.1.6;Box 25.2 Cannulas;167
8.3.1.7;Box 25.3 Commonly Used Infusion and Aspiration Pumps;168
8.3.1.8;Box 25.4 Commonly Used Sedatives and Anal­gesics15;170
8.3.1.9;Box 25.5 Liposuction Cosmetic Units;171
8.3.1.10;Box 25.6 Anatomic Sites and Liposuction Aggres­sive­ness17;171
8.3.1.11;Appendix A: Medications Which Inhibit Cytochrome P450;183
8.3.1.12;Appendix B: Medications that May Affect Bleeding;184
8.3.2;References;184
8.4;Chapter 26;185
8.4.1;Skin Tightening Off the Face with Radiofrequency and Broadband Light;185
8.4.1.1;Introduction;185
8.4.1.2;Clinical Examination/Patient Selection;185
8.4.1.3;Method of Device/Treatment Application;185
8.4.1.3.1;Dose/Setting Selection;185
8.4.1.3.2;Treatment Technique when using RF;187
8.4.1.3.3;Treatment Technique when using IBBL;189
8.4.1.3.4;Postoperative Care;189
8.4.1.3.5;Number and Frequency of Treatments;189
8.4.1.3.6;Management of Adverse Events;190
8.4.1.4;Direction for the Future/Conclusion;191
8.4.2;References;191
8.5;Chapter 27;192
8.5.1;Female Genital Surgery;192
8.5.1.1;Introduction;192
8.5.1.2;Functional and Aesthetic Labia Minora Reduction;192
8.5.1.2.1;Introduction and Definition;192
8.5.1.2.2;Clinical Examination and Patient History;192
8.5.1.2.3;Treatment Application;193
8.5.1.3;Vulvar Reshaping and Vaginal Rejuvenation;195
8.5.1.3.1;Introduction and Definition;195
8.5.1.3.2;Clinical Examination and Patient History;195
8.5.1.3.3;Treatment Application;195
8.5.1.3.3.1;Volume Augmentation of the Mons Veneris and Labia Majora;195
8.5.1.3.3.2;Re-structuring, Hydration, and Turgescence of Vulvo-vaginal Mucosae;196
8.5.2;References;196
8.6;Chapter 28;197
8.6.1;Reduction of Excess Abdominal Skin via Liposuction and Surgical Excision;197
8.6.1.1;Introduction;197
8.6.1.2;Clinical Examination and Patient History;197
8.6.1.3;Method of Device and Treatment Application;198
8.6.1.4;Postoperative care;199
8.6.1.5;Possible Complications;201
8.6.1.6;Conclusion;202
8.6.2;References;202
9;Part VII Advanced and General Topics;203
9.1;Chapter 29;204
9.1.1;Ablative Laser Resurfacing Off the Face;204
9.1.1.1;Introduction;204
9.1.1.2;Patient Selection;204
9.1.1.3;Method of Device and Treatment Application;204
9.1.1.3.1;Fractional Resurfacing;205
9.1.1.3.2;Treatment of Lesions on the Leg;207
9.2;Chapter 30;209
9.2.1;Prepackaged Injectable Soft-Tissue Rejuvenation of the Hand and Other Nonfacial Areas;209
9.2.1.1;Introduction;209
9.2.1.2;Clinical Examination;209
9.2.1.3;Treatment Application;210
9.2.1.3.1;Administration of CaHA in the Hand;210
9.2.1.3.2;CaHA in Other Nonfacial Areas;211
9.2.1.4;Conclusion;212
9.2.2;References;213
9.3;Chapter 31;214
9.3.1;Cosmeceuticals Off the Face;214
9.3.1.1;Introduction;214
9.3.1.2;Clinical Examination;214
9.3.1.2.1;Body Cosmeceutical Treatment Application;216
9.3.1.2.1.1;Cleansers;216
9.3.1.2.1.2;Exfoliants;216
9.3.1.2.1.3;Moisturizers;216
9.3.1.2.1.4;Sunscreens;217
9.3.1.2.1.5;Skin Lightening Agents;217
9.3.1.2.1.6;Antiaging Therapies;218
9.3.1.3;Conclusion;219
9.3.2;References;219
9.4;Chapter 32;220
9.4.1;Special Considerations in Asian Patients;220
9.4.1.1;Introduction;220
9.4.1.2;Treatment Applications;220
9.4.1.2.1;Botulinum Toxin A (Botox®);220
9.4.1.2.2;Laser and Radiofrequency Skin Rejuvenation;220
9.4.1.2.2.1;Laser Considerations in Asian Skin;220
9.4.1.2.2.2;Neck Rejuvenation;221
9.4.1.2.2.3;Body Contouring;221
9.4.1.2.2.4;Hypertrophic and Keloid Scars;223
9.4.1.2.2.5;Hair Removal;223
9.4.1.3;Conclusion;223
9.4.2;References;224
9.5;Chapter 33;225
9.5.1;Treatment and Prevention of Dyspigmentation in Patients with Ethnic Skin;225
9.5.1.1;Introduction;225
9.5.1.2;Clinical Examination and Patient History;225
9.5.1.3;Treatment Application of Dyspigmentation in Ethnic Skin;226
9.5.1.3.1;Hydroquinone;227
9.5.1.3.1.1;Dose Selection;227
9.5.1.3.1.2;Treatment Technique;227
9.5.1.3.1.3;Alternative Treatment Methods;227
9.5.1.3.1.4;Management of Adverse Effects;227
9.5.1.3.2;Azelaic Acid;228
9.5.1.3.2.1;Dose Selection and Treatment Techniques;228
9.5.1.3.2.2;Management of Adverse Effects;228
9.5.1.3.3;Keratolytic Agents (a-Hydroxy Acids and b-Hydroxy Acid);228
9.5.1.3.3.1;Dose Selection and Treatment Technique;228
9.5.1.3.3.2;Management of Adverse Effects;228
9.5.1.3.4;Topical Glucocorticoids;228
9.5.1.3.5;Examples of Class V–VII Glucocorticoids;228
9.5.1.3.6;Laser Therapy;228
9.5.1.4;Conclusion;229
9.5.2;References;229
10;Index;230